STAGE II-IIIA

Clinical trials for STAGE II-IIIA explained in plain language.

Never miss a new study

Get alerted when new STAGE II-IIIA trials appear

Sign up with your email to follow new studies for STAGE II-IIIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo aims to shrink tumors before lung cancer surgery

Disease control Completed

This study tested whether adding the immunotherapy drug serplulimab to standard chemotherapy, given both before and after surgery, could help people with operable non-small cell lung cancer. The goal was to see if this combination could shrink tumors more effectively before surge…

Matched conditions: STAGE II-IIIA

Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control

Last updated Mar 23, 2026 15:19 UTC

STAGE II-IIIA

Get alerted when new STAGE II-IIIA trials appear

New drug combo aims to shrink tumors before lung cancer surgery